IT8023072A0 - Tetra-peptidi oppure penta-peptidi, loro preparazione e prodotti medicinali che li contengono. - Google Patents

Tetra-peptidi oppure penta-peptidi, loro preparazione e prodotti medicinali che li contengono.

Info

Publication number
IT8023072A0
IT8023072A0 IT8023072A IT2307280A IT8023072A0 IT 8023072 A0 IT8023072 A0 IT 8023072A0 IT 8023072 A IT8023072 A IT 8023072A IT 2307280 A IT2307280 A IT 2307280A IT 8023072 A0 IT8023072 A0 IT 8023072A0
Authority
IT
Italy
Prior art keywords
peptides
penta
tetra
contain
preparation
Prior art date
Application number
IT8023072A
Other languages
English (en)
Other versions
IT1131395B (it
Inventor
Bouchaudon Jean
Farge Daniel
James Claude
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of IT8023072A0 publication Critical patent/IT8023072A0/it
Application granted granted Critical
Publication of IT1131395B publication Critical patent/IT1131395B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT23072/80A 1979-06-29 1980-06-26 Tetra-peptidi oppure penta-peptidi,loro preparazione e prodotti medicinali che li contengono IT1131395B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7916845A FR2460290A1 (fr) 1979-06-29 1979-06-29 Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent

Publications (2)

Publication Number Publication Date
IT8023072A0 true IT8023072A0 (it) 1980-06-26
IT1131395B IT1131395B (it) 1986-06-18

Family

ID=9227279

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23072/80A IT1131395B (it) 1979-06-29 1980-06-26 Tetra-peptidi oppure penta-peptidi,loro preparazione e prodotti medicinali che li contengono

Country Status (16)

Country Link
US (1) US4742048A (it)
JP (1) JPS5636440A (it)
AU (1) AU544863B2 (it)
BE (1) BE884077A (it)
CH (1) CH651577A5 (it)
DE (1) DE3024281A1 (it)
DK (1) DK154940C (it)
FR (1) FR2460290A1 (it)
GB (1) GB2053231B (it)
IE (1) IE51058B1 (it)
IT (1) IT1131395B (it)
LU (1) LU82567A1 (it)
NL (1) NL8003762A (it)
NZ (1) NZ194179A (it)
SE (1) SE448302B (it)
ZA (1) ZA803887B (it)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458078A (en) * 1978-11-14 1984-07-03 Fujisawa Pharmaceutical Company, Ltd. Oxazole derivatives
US4749691A (en) * 1978-11-14 1988-06-07 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US4539155A (en) * 1978-11-14 1985-09-03 Fuisawa Pharmaceutical Company, Ltd. New peptide, process for preparation thereof and use thereof
US4354966A (en) 1978-11-14 1982-10-19 Fujisawa Pharmaceutical Co., Ltd. Peptides, process for preparation thereof and use thereof
US4801580A (en) * 1978-11-14 1989-01-31 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same
DE3070278D1 (en) * 1979-10-11 1985-04-18 Fujisawa Pharmaceutical Co Peptides, processes for their preparation and pharmaceutical compositions containing them
JPS57114556A (en) * 1980-10-27 1982-07-16 Fujisawa Pharmaceut Co Ltd Novel peptide compound and its preparation
IE51684B1 (en) * 1980-10-27 1987-02-04 Fujisawa Pharmaceutical Co Peptides,process for their preparation and pharmaceutical compositions containing them
DK465681A (da) * 1980-11-11 1982-05-12 Fujisawa Pharmacetical Co Ltd Fremgangsmaade til fremstilling af peptidderivater
GR81332B (it) * 1980-12-01 1984-12-11 Fujisawa Pharmaceutical Co
US4497729A (en) * 1980-12-01 1985-02-05 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2496654A1 (fr) * 1980-12-19 1982-06-25 Rhone Poulenc Sante Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
US4493794A (en) * 1980-12-31 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
JPH068312B2 (ja) * 1981-01-29 1994-02-02 藤沢薬品工業株式会社 新規ペプチドの製造法
US4399066A (en) 1981-01-29 1983-08-16 Fujisawa Pharmaceutical Co., Ltd. Novel peptide, process for preparation thereof and use thereof
GR79114B (it) * 1981-01-29 1984-10-02 Fujisawa Pharmaceutical Co
GR77929B (it) 1981-01-29 1984-09-25 Fujisawa Pharmaceutical Co
US4504471A (en) * 1982-09-27 1985-03-12 Fujisawa Pharmaceutical Co., Ltd. Animal growth promotant and method of use for animal growth
EP0114787B1 (de) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Neue Peptidderivate
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
WO1990003180A1 (en) * 1988-09-30 1990-04-05 Immunobiology Research Institute, Inc. Peptides having t cell suppressor activity
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5312831A (en) * 1993-05-12 1994-05-17 American Cyanamid Company Urethanes and ureas that induce cytokine production
EP0697884B1 (en) * 1993-05-14 1999-11-17 Mallinckrodt Inc. Ligand precursors for incorporation into peptides
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds
EP0922958B1 (de) * 1997-12-11 2002-10-02 Roche Diagnostics GmbH Entstörung von diagnostischen Verfahren durch Peptide aus D-Aminosäuren
AU1581400A (en) * 1999-12-22 2001-07-03 Om Pharma Acyl pseudopeptides bearing a functionalised auxiliary spacer
EP3323424A1 (en) 2016-11-17 2018-05-23 Cyanimal IP Cyaa polypeptides as immune enhancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442889A1 (fr) * 1978-10-19 1980-06-27 Anvar Nouveaux composes hydrosolubles provenant d'extraits de streptomyces stimulosus, leur obtention, leur application a titre d'adjuvants immunologiques et compositions les contenant
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
EP0013856B1 (en) * 1978-12-22 1983-03-09 ANVAR Agence Nationale de Valorisation de la Recherche New compounds associating peptidyl or aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds

Also Published As

Publication number Publication date
DK154940C (da) 1989-05-29
JPH0159276B2 (it) 1989-12-15
IE51058B1 (en) 1986-09-17
AU5970080A (en) 1981-01-08
CH651577A5 (fr) 1985-09-30
IE801342L (en) 1980-12-29
GB2053231B (en) 1983-09-07
BE884077A (fr) 1980-12-29
DE3024281A1 (de) 1981-01-08
LU82567A1 (fr) 1981-02-03
IT1131395B (it) 1986-06-18
NZ194179A (en) 1983-11-18
FR2460290A1 (fr) 1981-01-23
SE448302B (sv) 1987-02-09
JPS5636440A (en) 1981-04-09
NL8003762A (nl) 1980-12-31
US4742048A (en) 1988-05-03
AU544863B2 (en) 1985-06-20
GB2053231A (en) 1981-02-04
DK154940B (da) 1989-01-09
ZA803887B (en) 1981-07-29
SE8004792L (sv) 1980-12-30
DK277780A (da) 1980-12-30
FR2460290B1 (it) 1983-12-16

Similar Documents

Publication Publication Date Title
IT8023072A0 (it) Tetra-peptidi oppure penta-peptidi, loro preparazione e prodotti medicinali che li contengono.
IT8026522A0 (it) Farmaceutici a lunga azione procedimento e composizione per la controllata. preparazione di prodotti
IT1100185B (it) 1,4-di-idro-piridine nitro-sostituite,procedimenti per la loro preparazione e loro impiego come prodotti medicinali
IT1113128B (it) Prodotti antielmintici,procedimento per la loro preparazione e loro impiego
IT8125703A0 (it) Tri-peptidi, tetra-peptidi o penta-peptidi, loro preparazione e farmaci che li contengono.
IT8021464A0 (it) Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici, procedimento per la loro preparazione e prodotti medicinali che le contengono.
IT8220758A0 (it) Prodotti farmaceutici informa-ritardo e procedimento per ottenerli.
IT7821336A0 (it) Pseudo-trissaccaridi, procedimenti per la loro preparazione e loro impiego come prodotti medicinali.
IT8023392A0 (it) N-propionilsarcosinanilidi, procedimento per la loro preparazione e prodotti medicinali a base di queste sostanze.
IT1085949B (it) 2-benzil-pirrolidine,procedimento per la loro preparazione e prodotti medicinali che le contengono
IT1198331B (it) Dipeptidi,loro preparazione e prodotti medicinali che li contengono
IT7830474A0 (it) 1-n-aril-1,4-di-idro-piridine e il loro impiego come prodotti medicinali.
IT8023074A0 (it) Tripeptidi, loro preparazione e prodotti medicinali che licontengono.
IT7821651A0 (it) Prodotti disinfestanti, procedimento per la loro preparazione e loro impiego.
IT1109968B (it) Prodotti antielmintici,procedimento per la loro preparazione e loro impiego
IT7919651A0 (it) Prodotti microbicidi e procedimento per la loro preparazione.
IT7821696A0 (it) Prodotti microbicidi procedimenti per la loro preparazione e loro impiego.
IT1088927B (it) Ossime o-alchialte,procedimente per la loro preparazione e loro impiego come prodotti medicinali
IT7827564A0 (it) 1,4-di-idro-piridazine, procedimento per la loro preparazione e loro impiego come prodotti medicinali.
IT7820221A0 (it) Impiego. prodotti microbicidi, procedimento per la loro preparazione e loro
IT1194158B (it) Carbacicline,procedimento per la loro preparazione e loro impiego come medicinali
IT7919650A0 (it) Prodotti microbicidi e procedimento per la loro preparazione.
IT7821653A0 (it) Prodotti microbicidi, procedimento per la loro preparazione e loro impiego.
IT8026911A0 (it) Impiego. prodotti farmaceutici con caroverin e/o sali di caroverin e anche loro
IT7831447A0 (it) Acidi acil-idrocarbilammino-alcanoici, loro preparazione e loro impiego e anche prodotti medicinali che licontengono.